Upcoming Conferences, Contract Award, Quarterly Financial Results, and Completion of Acquisition - Research Reports on Bristol-Myers Squibb, 3M, Colony Financial, NOV and PPG

NEW YORK, November 10, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Bristol-Myers Squibb Company (NYSE: BMY), 3M Company (NYSE: MMM), Colony Financial, Inc. (NYSE: CLNY), National Oilwell Varco, Inc. (NYSE: NOV) and PPG Industries Inc. (NYSE: PPG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7815-100free.

--
Bristol-Myers Squibb Company Research Reports
On November 4, 2014, Bristol-Myers Squibb Company (Bristol-Myers Squibb) issued a press release stating that the Company will present at the Credit Suisse Annual Health Care Conference on November 11, 2014 in Phoenix. Bristol-Myers Squibb informed that Charles Bancroft, Executive Vice President and CFO, will make a formal presentation about the Company at 8:30 a.m. MST (10:30 a.m. EST). Additionally the live webcast of the presentation will be available at investors section of Bristol-Myers Squibb's website. The full research reports on Bristol-Myers Squibb are available to download free of charge at:

http://www.analystsreview.com/Nov-10-2014/BMY/report.pdf

--
3M Company Research Reports
On November 5, 2014, 3M Company (3M) reported that Rhode Island All-Payer Claims Database (RI-APCD) has selected the Company's subsidiary, 3M Health Information Systems to provide quality assurance, data management, analytics, access and reporting of RI-APCD data. The Company informed that RI-APCD is a new initiative that will provide data about hospital quality and cost to facilitate better healthcare decisions. As per 3M, RI-APCD is a large-scale database that systematically collects and aggregates enrollment, medical claims, pharmacy claims, and provider data from commercial insurers and public payers such as Medicare and Medicaid. William Kelly, Senior Vice President, 3M Health Information Systems, said, "The experience we have gained in our work with four multi-payer state initiatives, as well as payer-provider collaborations, will strengthen and enrich the Rhode Island APCD experience." The full research reports on 3M are available to download free of charge at:

http://www.analystsreview.com/Nov-10-2014/MMM/report.pdf

--
Colony Financial, Inc. Research Reports
On November 5, 2014, shares of real estate investment and finance Company - Colony Financial, Inc. (Colony Financial) touched a new 52-week high of $24.20, after the Company reported Q3 2014 earrings that exceeded analysts' estimates. Core earnings for the quarter were $42.8 million or $0.38 per diluted share, compared to $25.7 million or $0.38 per diluted share in Q3 2013. On average, analysts polled by Thomson Reuters expected the Company to report earnings of (excluding special items) $0.37 per share, for the quarter. Total income for Q3 2014 rose to $77.3 million, compared to $47.5 million in Q3 2013. Shares of the Company gained 8.71% to end at $24.08, the same day. The Company also announced an increased dividend of $0.37 per common share for Q4 2014, payable on January 15, 2015 to stockholders of record on December 31, 2014. The full research reports on Colony Financial are available to download free of charge at:

http://www.analystsreview.com/Nov-10-2014/CLNY/report.pdf

--
National Oilwell Varco, Inc. Research Reports
As per the Events section on the official website of National Oilwell Varco, Inc. (NOV), the Company will participate at the Abu Dhabi Petroleum Conference and Exhibition, at Abu Dhabi National Exhibitions Center, Booth 7310, between November 10 - November 13, 2014. The full research reports on NOV are available to download free of charge at:

http://www.analystsreview.com/Nov-10-2014/NOV/report.pdf

--
PPG Industries Inc. Research Reports
On November 5, 2014, PPG Industries Inc. (PPG) said that it has finalized the acquisition of Consorcio Comex, S.A. de C.V. ("Comex"), an architectural coatings company with headquarters in Mexico City, in a transaction valued at $2.3 billion. Commenting on the development, Charles E. Bunch, PPG Chairman and CEO, said "We are pleased to have successfully completed this acquisition, the second-largest in our company's history, as it adds a leading architectural coatings business in Mexico and Central America to our portfolio. We look forward to working with the Comex team as we integrate the business into PPG." On October 31, 2014, PPG informed that it has received a favorable ruling from Mexico's Federal Economic Competition Commission on its previously announced agreement to acquire Comex. The full research reports on PPG are available to download free of charge at:

http://www.analystsreview.com/Nov-10-2014/PPG/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review